调节额部脑电α振荡以改善老年患者麻醉后早期神经认知恢复:随机对照试验方案
本研究为2×2析因、双盲、分层随机对照试验,计划纳入600例60岁及以上接受非心脏、非颅内挥发性麻醉且预计时长超过2小时的患者。旨在评估在麻醉维持期最大化额部脑电α功率的滴定策略,以及在苏醒期早期停用挥发性麻醉药并过渡到丙泊酚苏醒的策略,能否预防麻醉后监护室(PACU)谵妄。主要研究结局为维持期和苏醒期额部α振荡功率,主要临床结局为PACU谵妄。
要点
- 维持期采用α功率最大化滴定策略对比常规避免脑电抑制模式。
- 苏醒期采用早期停挥发性麻醉药并丙泊酚苏醒对比常规挥发性麻醉苏醒。
- 主要临床结局为PACU谵妄,尚属探索性研究。
核心结论
- 旨在评估两种通过最大化额部脑电α振荡的麻醉策略能否预防PACU谵妄。
- 该研究为探索性研究,脑电特征可被药物滴定改变的程度尚不明确。
研究设计与样本
- 2×2析因、双盲、分层随机对照试验,纳入600例60岁及以上患者。
- 纳入标准:非心脏、非颅内、挥发性麻醉且预计时长超过2小时。
- 按术前认知状态、手术类型和部位进行分层。
主要发现
- 主要研究结局为维持期和苏醒期额部α振荡功率。
- 主要临床结局为PACU谵妄。
关键数值与推荐
- 维持期随机1:1分为α功率最大化滴定策略组与常规避免脑电抑制模式组。
- 苏醒期随机1:1分为早期停用挥发性麻醉药并丙泊酚苏醒组与常规挥发性麻醉苏醒组。
临床怎么用
- 干预措施均为临床麻醉中已使用的策略,但尚未被正式评估。
- 在儿童中苏醒期加用丙泊酚可减少苏醒期谵妄,但在老年患者中的疗效未知。
局限性
- 研究为探索性,脑电特征可被药物滴定改变的程度尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative delirium may manifest in the immediate post-anaesthesia care period. Such episodes appear to be predictive of further episodes of inpatient delirium and associated adverse outcomes. Frontal electroencephalogram (EEG) findings of suppression patterns and low proprietary index values have been associated with postoperative delirium and poor outcomes. However, the efficacy of titrating anaesthesia to proprietary index targets for preventing delirium remains contentious. We aim to assess the efficacy of two strategies which we hypothesise could prevent post-anaesthesia care unit (PACU) delirium by maximising the alpha oscillation observed in frontal EEG channels during the maintenance and emergence phases of anaesthesia. METHODS: This is a 2 × 2 factorial, double-blind, stratified, randomised control trial of 600 patients. Eligible patients are those aged 60 years or over who are undergoing non-cardiac, non-intracranial, volatile-based anaesthesia of expected duration of more than 2 h. Patients will be stratified by pre-operative cognitive status, surgery type and site. For the maintenance phase of anaesthesia, patients will be randomised (1:1) to an alpha power-maximisation anaesthesia titration strategy versus standard care avoiding suppression patterns in the EEG. For the emergence phase of anaesthesia, patients will be randomised (1:1) to early cessation of volatile anaesthesia and emergence from an intravenous infusion of propofol versus standard emergence from volatile anaesthesia only. The primary study outcomes are the power of the frontal alpha oscillation during the maintenance and emergence phases of anaesthesia. Our main clinical outcome of interest is PACU delirium. DISCUSSION: This is a largely exploratory study; the extent to which EEG signatures can be modified by titration of pharmacological agents is not known. The underlying concept is maximisation of anaesthetic efficacy by individualised drug titration to a clearly defined EEG feature. The interventions are already clinically used strategies in anaesthetic practice, but have not been formally evaluated. The addition of propofol during the emergence phase of volatile-based general anaesthesia is known to reduce emergence delirium in children; however, the efficacy of this strategy in older patients is not known. TRIAL REGISTRATION: Australian and New Zealand Clinical Trial Registry, ID: 12617001354370 . Registered on 27/09/2017.
引用
- Gaskell A, Pullon R, Hight D, et al. Modulation of frontal EEG alpha oscillations during maintenance and emergence phases of general anaesthesia to improve early neurocognitive recovery in older patients: protocol for a randomised controlled trial. Trials. 2019. PMID: 30795794. doi:10.1186/s13063-019-3178-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。